Philips

Philips is a technology company focused on improving people's health and well-being through meaningful innovation. The company aims to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. Driven by purpose, Philips operates sustainably, adhering to high Environmental, Social and Governance (ESG) standards while partnering with healthcare providers, start-ups, universities and other companies. The company's history of ground-breaking innovation stretches back over 130 years with a continued focus on customers' needs. Philips is a responsible company that cares about people and the planet.

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

85%

Examples:

  • CEO Roy Jakobs expressed confidence in the performance improvement plan for 2024 despite challenges from Respironics recall and litigation
  • Income from operations was EUR -824 million, including a provision of EUR 982 million for Respironics litigation settlement

Deceptions

100%

Examples:

No current examples available.

Recent Articles

  • Philips Agrees to $1.1 Billion Settlement Over Cancer Risks in Recalled Sleep Apnea Devices

    Philips Agrees to $1.1 Billion Settlement Over Cancer Risks in Recalled Sleep Apnea Devices

    Broke On: Monday, 29 April 2024 Philips, a Dutch medical devices company, reached a $1.1 billion settlement in the US to resolve personal injury lawsuits related to its recalled sleep apnea devices made by subsidiary Philips Respironics due to cancer risk concerns. The settlement covers payments expected in 2025 and is funded through cash flow generation, with insurers contributing €540 million for claims. Despite losses of €1.3 billion in 2023-Q1 2024 on sales of €4.1 billion, Philips shares surged following the announcement.